Authors: Stieber, P Molina, R Chan, DW Fritsche, HA Beyrau, R Bonfrer, JMG Filella, X Gornet, TG Hoff, T Jager, W van Kamp, GJ Nagel, D Peisker, K Sokoll, LJ Troalen, F Untch, M Domke, I

Citation: P. Stieber et al., Evaluation of the analytical and clinical performance of the Elecsys (R) CA 15-3 immunoassay, CLIN CHEM, 47(12), 2001, pp. 2162-2164

Authors: Gaarenstroom, KN Kenter, GG Bonfrer, JMG Korse, CM Van de Vijver, MJ Fleuren, GJ Trimbos, JB

Citation: Kn. Gaarenstroom et al., Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cellcervical cancer predict lymph node metastases or prognosis?, GYNECOL ONC, 77(1), 2000, pp. 164-170

Authors: Klaase, JM Swaanenburg, JCJM Schouwink, H Sosef, MN Bonfrer, JMG Zoetmulder, FAN Rutgers, EJT Baas, P

Citation: Jm. Klaase et al., Monitoring of impending myocardial damage after pleuropneumonectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma using biochemical markers, PHOTOCHEM P, 71(3), 2000, pp. 351-354

Authors: Toniolo, P Bruning, PF Akhmedkhanov, A Bonfrer, JMG Koenig, KL Lukanova, A Shore, RE Zeleniuch-Jacquotte, A

Citation: P. Toniolo et al., Serum insulin-like growth factor-I and breast cancer, INT J CANC, 88(5), 2000, pp. 828-832

Authors: Schouwink, H Korse, CM Bonfrer, JMG Hart, AAM Baas, P

Citation: H. Schouwink et al., Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma, LUNG CANC, 25(1), 1999, pp. 25-32